Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acetate, Lysine
2. Enisyl
3. L Lysine
4. L-lysine
5. Lysine
6. Lysine Acetate
7. Lysine Hydrochloride
1. 657-27-2
2. L-lysine Monohydrochloride
3. Lysine Hydrochloride
4. L-lysine, Monohydrochloride
5. 10098-89-2
6. H-lys-oh.hcl
7. L-(+)-lysine Monohydrochloride
8. L-lysine Hcl
9. (s)-2,6-diaminohexanoic Acid Hydrochloride
10. Lysine Hcl
11. Lyamine
12. L-lysine Monohydrocholoride
13. L-lysinehydrochloride>99%
14. Lysine Hcl, L-
15. Darvyl
16. Enisyl
17. Lysion
18. (2s)-2,6-diaminohexanoic Acid Hydrochloride
19. L-gen
20. Jnj23q2com
21. Poly(l-lysine) Hydrochloride
22. Lysine, L-, Monohydrochloride
23. Lysine, Monohydrochloride
24. Chebi:53633
25. Nsc-9253
26. Mfcd00064564
27. L-lysine, Hydrochloride
28. (s)-2,6-diaminohexanoic Acid Hydrochloride(1:x)
29. (2s)-2,6-diaminohexanoic Acid;hydrochloride
30. Lysine Hydrochloride (van)
31. 28826-16-6
32. L-lysine Hydrochloride (van)
33. Lysine, Monohydrochloride, L-
34. L-lysine, Hydrochloride (1:?)
35. Nsc 9253
36. Einecs 211-519-9
37. Unii-jnj23q2com
38. L(+)-lysine Monohydrochloride
39. Ai3-52405
40. (s)-2,6-diaminohexanoic Acid Monohydrochloride
41. Einecs 233-234-9
42. Lysine Hydrochloride [usan:usp:jan]
43. L-lysine.hydrochloride
44. H-lys-oh⋅hcl
45. H-lys-oh?cl
46. L-lysine-hydrochloride
47. Lysine Hcl [inci]
48. Ec 211-519-9
49. Lysine Hydrochloride (usp)
50. L-lysine Hydrochloride,(s)
51. Schembl41761
52. L-lysine Hydrochloride Solution
53. L(+)-lysine Monohy-drochloride
54. Chembl2105886
55. Dtxsid9029198
56. L-lysine Hydrochloride (jp17)
57. L-lysine, Hydrochloride (1:1)
58. Lysine Hydrochloride [jan]
59. Pharmakon1600-01301003
60. Lysine Hydrochloride [usan]
61. Hy-n0470
62. Lysine Hydrochloride [vandf]
63. L-lysine Hydrochloride [jan]
64. Lysine Hydrochloride [mart.]
65. Lysine Monohydrochloride [mi]
66. Nsc760110
67. S3953
68. Lysine Hydrochloride [who-dd]
69. Akos015847945
70. Akos015892881
71. Am81901
72. Ccg-214725
73. Cs-7885
74. Nsc-760110
75. L-lysine Hydrochloride [usp-rs]
76. L-lysine Monohydrochloride [fcc]
77. Ac-23978
78. Bs-17408
79. Lysine Hydrochloride [ep Monograph]
80. Db-029969
81. L-lysine Monohydrochloride, P.a., 98.5%
82. Lysine Hydrochloride [usp Monograph]
83. L0071
84. L-lysine Hydrochloride, >=98%, Natural, Fg
85. Lysine Hydrochloride (l-lysine Hydrochloride)
86. D02279
87. D70613
88. M03093
89. 657l272
90. A800311
91. J-521652
92. L-alpha,epsilondiaminocaproic Acid Monohydrochloride
93. Q-100750
94. L-lysine Monohydrochloride, Bioultra, >=99.5% (at)
95. Q27124123
96. Z940713328
97. L-lysine Monohydrochloride, Reagent Grade, >=98% (hplc)
98. L-lysine Monohydrochloride, Saj Special Grade, >=99.0%
99. L-lysine Monohydrochloride, Vetec(tm) Reagent Grade, >=98%
100. H-lys-oh.hcl L-lysine Monohydrochloride (from Non-animal Source)
101. L-lysine Monohydrochloride, Cell Culture Reagent (h-l-lys-oh.hcl)
102. Lysine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
103. L-lysine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
104. L-lysine Monohydrochloride, Certified Reference Material, Tracecert(r)
105. L-lysine Hydrochloride Solution, 100 Mm Amino Acid In 0.1 M Hcl, Analytical Standard
106. L-lysine Monohydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
107. L-lysine Monohydrochloride, From Non-animal Source, Meets Ep, Jp, Usp Testing Specifications, Suitable For Cell Culture, 98.5-101.0%
108. L-lysine Monohydrochloride, Pharmagrade, Ajinomoto, Ep, Jp, Usp, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production, Suitable For Cell Culture
| Molecular Weight | 182.65 g/mol |
|---|---|
| Molecular Formula | C6H15ClN2O2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 182.0822054 g/mol |
| Monoisotopic Mass | 182.0822054 g/mol |
| Topological Polar Surface Area | 89.3 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 106 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A L-Lysine-Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Lysine-Hydrochloride, including repackagers and relabelers. The FDA regulates L-Lysine-Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Lysine-Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Lysine-Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Lysine-Hydrochloride supplier is an individual or a company that provides L-Lysine-Hydrochloride active pharmaceutical ingredient (API) or L-Lysine-Hydrochloride finished formulations upon request. The L-Lysine-Hydrochloride suppliers may include L-Lysine-Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of L-Lysine-Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Lysine-Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Lysine-Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of L-Lysine-Hydrochloride DMFs exist exist since differing nations have different regulations, such as L-Lysine-Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Lysine-Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. L-Lysine-Hydrochloride USDMF includes data on L-Lysine-Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Lysine-Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Lysine-Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The L-Lysine-Hydrochloride Drug Master File in Japan (L-Lysine-Hydrochloride JDMF) empowers L-Lysine-Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the L-Lysine-Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of L-Lysine-Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of L-Lysine-Hydrochloride suppliers with JDMF on PharmaCompass.
A L-Lysine-Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a L-Lysine-Hydrochloride Certificate of Suitability (COS). The purpose of a L-Lysine-Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L-Lysine-Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L-Lysine-Hydrochloride to their clients by showing that a L-Lysine-Hydrochloride CEP has been issued for it. The manufacturer submits a L-Lysine-Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a L-Lysine-Hydrochloride CEP holder for the record. Additionally, the data presented in the L-Lysine-Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L-Lysine-Hydrochloride DMF.
A L-Lysine-Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L-Lysine-Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L-Lysine-Hydrochloride suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Lysine-Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Lysine-Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Lysine-Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Lysine-Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Lysine-Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Lysine-Hydrochloride suppliers with NDC on PharmaCompass.
L-Lysine-Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Lysine-Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Lysine-Hydrochloride GMP manufacturer or L-Lysine-Hydrochloride GMP API supplier for your needs.
A L-Lysine-Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to L-Lysine-Hydrochloride's compliance with L-Lysine-Hydrochloride specifications and serves as a tool for batch-level quality control.
L-Lysine-Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each L-Lysine-Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Lysine-Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Lysine-Hydrochloride EP), L-Lysine-Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Lysine-Hydrochloride USP).
LOOKING FOR A SUPPLIER?
